Treatment for Indeterminate BV with Concurrent Yeast Infection

Management of Concurrent Candida Infection

The Centers for Disease Control and Prevention recommends oral fluconazole 150 mg as a single dose for the treatment of uncomplicated vulvovaginal candidiasis (VVC) 1
Alternative topical options for VVC treatment include clotrimazole 1% cream 5g intravaginally for 7-14 days, miconazole 2% cream 5g intravaginally for 7 days, terconazole 0.4% cream 5g intravaginally for 7 days, and tioconazole 6.5% ointment 5g intravaginally in a single application 1, 2, 3
Topical treatments may be preferred for severe symptoms requiring immediate relief 1
Oil-based creams and suppositories may weaken latex condoms and diaphragms 2
Multi-day regimens (3-7 days) are preferred for severe or complicated VVC 4

Confirm diagnosis with appropriate testing, such as wet mount microscopy with KOH preparation, which can identify yeast cells/pseudohyphae 1, 4
Normal vaginal pH (≤4.5) is typically associated with Candida infection, while BV usually shows elevated pH 4
Molecular testing (PCR) for Candida has higher sensitivity (90.7%) and specificity (93.6%) than clinical diagnosis if available 1
Approximately 10-20% of women normally harbor Candida without symptoms, and asymptomatic Candida colonization should not be treated 3, 4
Avoid simultaneous treatment of sexual partners for Candida as VVC is not typically sexually transmitted 2, 3
Self-medication with OTC preparations should only be recommended for women previously diagnosed with VVC experiencing recurrence of the same symptoms 4
Patients should return for follow-up only if symptoms persist or recur within 2 months 2